Navigation Links
15 new conservation concerns
Date:12/12/2011

A review carried out by a group of international specialists has identified several emerging issues that are likely to damage biodiversity in the coming years.

The review was conducted by 22 specialists from 20 institutions, including the University of Cambridge and the European Centre for Environment and Human Health, and aims to provide a 'critical list' of issues that need investigating in the near future.

The analysis focused on changes in climate, technology and human behaviour, with particular attention on the way developments in these areas could impact on the conservation of biodiversity. The authors hope that by identifying these issues, which are often at the very edge of our current understanding, researchers and policy-makers can be given early warning of what tomorrow's problems are likely to be allowing them to take appropriate preventative action now.

A total of 15 issues have been highlighted by the review, each focusing on a specific development. One of the issues is the potentially damaging impact of pharmaceuticals that are released into the environment after human use. As populations age and our use of drugs increases, these chemicals are beginning to affect fish, birds and other organisms, but the larger scale impact on our ecosystems is mostly unknown. Another area identified by the study highlights the increasing use of nuclear batteries and the safe disposal of their waste. These novel power sources could provide electricity to remote and deprived communities but the implications for the environment are yet to be determined.

In order to identify each issue, the team used a technique referred to as Horizon Scanning. This method is regularly used by businesses to identify new market opportunities and scientists use it in a similar way - to determine emerging areas of concern that will need to be investigated. As with business, the successful use of this technique will allow researchers to expose issues with enough time to react, and hopefully lessen their impact.

The European Centre for Environment & Human Health (part of the Peninsula College of Medicine & Dentistry) is a co-sponsor of the review together with the University of Cambridge and the Natural Environment Research Council. The European Centre has already set its sights on several of the areas identified and regularly conducts its own horizon scanning activities.

Professor Michael Depledge, co-author of the study and a leading specialist at the Centre said

"This review has highlighted a number of issues that are likely to be of great importance throughout the 21st century. From the warming of the deep sea to placing hydro-electric turbines in rivers, it is clear that our potential to damage the natural environment will continue to be a crucial area in which we should conduct research. By identifying these issues at an early stage we hope to gain an understanding that can drive changes in policy and behaviour, ultimately helping to preserve biodiversity and increase the adoption of sustainable ways of living."


'/>"/>

Contact: Andrew Gould
andrew.gould@pcmd.ac.uk
44-139-268-6107
The Peninsula College of Medicine and Dentistry
Source:Eurekalert

Related medicine news :

1. Young women with early breast cancer have similar survival with breast conservation, mastectomy
2. Research suggests that lipofilling may be safe during conservation treatment for breast cancer
3. Pharmaceutical conservation key to slowing rise of antibiotic-resistant infections
4. Concerns about teen sexting overblown, according to new UNH research
5. Internists address dual concerns of privacy and protection of health data
6. Internists express very substantial concerns over MedPAC physician pay proposal
7. Gonorrheas Growing Resistance to Antibiotics Concerns CDC
8. Safety concerns about adulterated drug ingredients
9. Results on national study of parental concerns about childhood vaccines announced
10. Study raises safety concerns about experimental cancer approach
11. Concerns Grow Over Dangers of Caffeinated Alcohol Drinks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... Guruji Mahendra ... 9th, 10th and 11th, 2016 in honor of his birthday on February 10th. ... happiness. Mahendra Trivedi is known by over 250,000 people from over 40 different ...
(Date:2/7/2016)... ... February 07, 2016 , ... Women’s Excellence now ... the most minimally invasive approaches. , Women who have had multiple vaginal births ... factors include surgery to the pelvic floor, connective tissue disorders, and obesity. Women ...
(Date:2/7/2016)... ... February 07, 2016 , ... Dr. Todd Hobgood , ... medical and surgical expertise. Technically known as deoxycholic acid or previously as ATX-101, ... non-surgical alternative for reduction of fat below the chin (aka the “double chin”). ...
(Date:2/6/2016)... ... February 06, 2016 , ... With the FCPX ... warm color grades to their footage. A LUT is a Lookup Table that contains ... the corresponding color indicated by the table. By manipulating each pixel, LUT's can change ...
(Date:2/5/2016)... ... , ... Steven Tonkinson, 36, of Coconut Grove, Florida, ran the Miami Marathon ... 2003. This year, he ran all 26.2 miles with a green 25-pound ShelterBox strapped ... Heat. , This Sunday, while many are watching the Superbowl, Steven Tonkinson will strap ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... -- HemaFlo Therapeutics, Inc. announced today that the United States Patent ... covering the use of NephroFlow to treat acute kidney injury ... said, "We are pleased to secure our rights to such ... PhD, HemaFlo,s founder, said, "We are pleased to secure our ... Dale Peterson , PhD, HemaFlo,s founder, said, "We are ...
(Date:2/8/2016)... , Feb. 8, 2016  Dynatronics Corporation ... of advanced-technology medical devices and rehabilitation equipment for ... congratulates the Denver Broncos, football team for winning ... Cullimore Jr. , Chairman and Chief Executive Officer.  ... and we look forward to enhancing their athletic ...
(Date:2/8/2016)... , Feb. 8, 2016  Sangamo BioSciences, ... therapeutic genome editing, announced that the U.S. Food ... Investigational New Drug (IND) application for SB-318, a ... therapy for Mucopolysaccharidosis Type I (MPS I). The ... Sangamo to initiate a Phase 1/2 clinical study ...
Breaking Medicine Technology: